Grupo Aeroportuario del Pacifico Announces Results for the First Quarter of 2024
GUADALAJARA, Mexico, April 22, 2024 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the […]
Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; Diluted Net Income Per Share – Adjusted of $1.14; and a quarterly dividend of $0.13 per share
DAYTONA BEACH, Fla., April 22, 2024 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE:BRO) (the “Company”) announced its unaudited financial […]
SmartFinancial Announces Results for the First Quarter 2024
KNOXVILLE, Tenn., April 22, 2024 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial” or the “Company”; NYSE: SMBK), today announced net income […]
Parker to Announce Fiscal 2024 Third Quarter Earnings on May 2; Conference Call and Webcast Scheduled for 11 a.m. Eastern Time
CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, […]
Scorpius Holdings Announces Receipt of Filing Delinquency Notification
DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing […]
Lithium Argentina to Release First Quarter 2024 Results on May 13, 2024
VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) — Lithium Americas (Argentina) Corp. (TSX: LAAC) (NYSE: LAAC) (“Lithium Argentina” or […]
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
– Lead product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human pancreatic mouse xenograft– […]
Theriva™ Biologics presentará datos preclínicos que apoyan la sinergia potencial entre el VCN-01 y los regímenes de quimioterapia de primera línea contra el cáncer de páncreas en la 27ª Reunión Anual de la Sociedad Americana de Terapia Celular y Genética
– El principal producto candidato, el VCN-01, en combinación con irinotecán liposomal, demostró mayores efectos antitumorales en un xenoinjerto pancreático […]
TopBuild Announces Mutual Termination of Agreement to Acquire Specialty Products and Insulation
TopBuild’s Total Addressable Market is >$18 Billion; Significant Opportunity to Continue Driving Growth Organically and through Acquisitions DAYTONA BEACH, Fla., […]
Archrock Announces Timing for First Quarter 2024 Results
HOUSTON, April 22, 2024 (GLOBE NEWSWIRE) — Archrock, Inc. (NYSE:AROC) (“Archrock”) will host a conference call on Wednesday, May 1, […]
